The aging and failure of cells that occurs when the liver is damaged can spread to other organs, suggests a new study in mice ...

The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...

The development of a novel, artificial intelligence (AI)-generated biotechnology has the potential to transform care options ...

Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...

In a small Phase IIa trial, Insilico’s generative AI-designed idiopathic pulmonary fibrosis drug improved lung function and ...

aDepartment of Molecular Medicine and the Center on Aging, The Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, United States bRobert and Arlene Kogod Center on Aging, Mayo Clinic, 200 ...

Oct 18 (Reuters) - United States Cellular (USM.N), opens new tab said on Friday it has agreed to sell some of its spectrum licenses to Verizon (VZ.N), opens new tab in a $1 billion deal.

U.S. Cellular agreed to sell part of its spectrum licenses to Verizon for $1.0 billion in cash, pending regulatory approval. Additional agreements with two mobile operators to sell more spectrum ...

The research provides a stepping stone toward therapies that can control cellular aging, promoting longer, healthier lives.

Idiopathic pulmonary fibrosis (IPF) is characterized by a progressive decline in lung function, worsening quality of life, and high mortality. However, the rate and pattern of progression of IPF ...

Patient enrollment for idiopathic inflammatory myopathy and ... Secondary objectives include measuring cellular kinetics, pharmacodynamics, changes in autoantibody titers, and appropriate disease ...